[PDF] Top 20 Lamivudine for chronic hepatitis B: a brief review

... for chronic hepatitis B was alpha-interferon; however, it gives only moderate efficacy in terms of sustained response (biochemical, virological and ...of lamivudine in adult patients affected ... See full document

... with chronic hepatitis B, we estimated that the rates of viro- logic response would be 25 percent among children in the lamivu- dine group and 9 percent among children in the placebo ...the ... See full document

... aim: Chronic hepatitis B is a highly prevalent disease worldwide, leading to seri- ous consequences if not properly ...for chronic hepatitis B are currently provided by the ... See full document

... Hepatitis B virus infection is an important public-health issue. Chronic patients have a higher risk of death due to complications, which increases health-care expenses ...versus lamivudine ... See full document

... SUMMARY. Lamivudine has been demonstrated safe and efficacious in the short term in a large cohort of children with chronic hepatitis B (CHB), but optimal duration of treatment has not been ... See full document

... to lamivudine (LMV) and the availability of new alterna- tive treatments for chronic hepatitis B patients, early detection of viral genotypic resistance could allow the clinician to consider ... See full document

... of chronic hepatitis B has been poorly studied in ...Here, hepatitis B virus (HBV) DNA positivity, drug resistance mutations and their association with HBV genotypes were evaluated in ... See full document

... months and another patient was HBeAg negative/ retrospective analysis of chronic HBV infection in- HBeAb negative. Of the two patients who were not dicated that 40% of adult Asian men with this dis- HBeAg ... See full document

... of lamivudine in 35 consecutive patients with CHB with evidence of viral ...had hepatitis B surface antigen (HBsAg) in serum for at least six months, detectable HBV-DNA in serum (34 by PCR and one by ... See full document

... Uvod. Hepatitis B virusna infekcija je globalni zdravstveni problem, jer predstavlja vodeći uzrok ciroze jetre i hepato- celularnog ...hepatitisa B uključuje primenu standardnih i pegilovanih ... See full document

... Although primary or secondary/compensatory NAs resistance mutations were not found in this studied population, there were a lot of putative NAs resistant mutations which have been reported to be selected during prolonged ... See full document

... with lamivudine in HBeAg- negative patients or those with advanced liver fibrosis, sustained viral suppression was associated with the de- crease in complications of cirrhosis and hepatocellular ... See full document

... prophylactic/preemptive lamivudine and of mycophenolate mofetil. Lamivudine use was the only variable independently associated with exacerbation, with a protective ... See full document

... This cross-sectional study was conducted at King Khalid Hospital, a 350-bed tertiary care hospital in Najran during a 6-month period from February to October 2014. A total of 160 patients with CHB infection, followed as ... See full document

... Chronic hepatitis B virus (HBV) infection is an im- portant public health problem affecting around 360 mil- lion people worldwide (Shepard et ... See full document

... tained on dialysis or submitted to transplan- tation (1,3). The real impact of transplanta- tion and treatment with immunosuppressive drugs on patients with chronic hepatitis B is not clear. It is ... See full document

... Patients with chronic renal insuficiency have increased risk for the infections by VHB and VHC. Lamivudine continues being important therapeutic option. The interferon has the main paper in the treatment of ... See full document

... Entecavir, an oral cyclopentyl guanosine analogue polymerase inhibitor, (the most potent of the HBV antivirals so far according to most of the studies), is not only just as well tolerated as lamivudine, with a ... See full document

... Cw*04 was reported to be in strong linkage disequilibrium with HLA- B*53 and HLA-B*35, and only the Cw*04-B*53 haplotype (OR, 1.76) correlated (albeit weakly) with viral persistence. Those authors ... See full document

... was performed using fixed-effects or random-effects model, depending on the absence or presence of significant hetero- geneity. When heterogeneity due to variability was significant (p > 0.1), a random-effects model ... See full document